G

Giant Biogene Holding Co Ltd
HKEX:2367

Watchlist Manager
Giant Biogene Holding Co Ltd
HKEX:2367
Watchlist
Price: 32 HKD 1.07% Market Closed
Market Cap: HK$34.3B

Net Margin

37%
Current
Declining
by 1.8%
vs 3-y average of 38.8%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
37%
=
Net Income
¥2.3B
/
Revenue
¥6.1B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
37%
=
Net Income
HK$2.3B
/
Revenue
¥6.1B

Peer Comparison

Country Company Market Cap Net
Margin
CN
Giant Biogene Holding Co Ltd
HKEX:2367
34.1B HKD
Loading...
FR
L'Oreal SA
PAR:OR
211.8B EUR
Loading...
UK
Unilever PLC
LSE:ULVR
119B GBP
Loading...
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.5T INR
Loading...
UK
HALEON PLC
LSE:HLN
35.9B GBP
Loading...
US
Estee Lauder Companies Inc
NYSE:EL
39.5B USD
Loading...
DE
Beiersdorf AG
XETRA:BEI
23.6B EUR
Loading...
JP
Kao Corp
TSE:4452
3T JPY
Loading...
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR
Loading...
IN
Dabur India Ltd
NSE:DABUR
924.4B INR
Loading...
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD
Loading...

Market Distribution

Higher than 95% of companies in China
Percentile
95th
Based on 8 721 companies
95th percentile
37%
Low
-416 945.9% — -1.5%
Typical Range
-1.5% — 8.9%
High
8.9% — 17 382.1%
Distribution Statistics
China
Min -416 945.9%
30th Percentile -1.5%
Median 3.5%
70th Percentile 8.9%
Max 17 382.1%

Giant Biogene Holding Co Ltd
Glance View

Market Cap
34.3B HKD
Industry
Consumer products

In the bustling entrepreneurial landscape of China's Xi'an comes a formidable player in the skincare industry—Giant Biogene Holding Co Ltd. Founded in the early 2000s, the company quickly established itself as a pioneer in the biocosmetic field, underpinned by its commitment to leveraging cutting-edge biotechnologies. Positioned at the intersection of science and beauty, Giant Biogene concentrates on the research, production, and sale of bioactive skincare ingredients and products. These formulations, rich in proteins and polypeptides, target aspiring consumers eager to invest in beauty products that promise both efficacy and luxury. The company’s emphasis on integrating advanced bioengineering techniques with traditional Chinese medicinal practices has allowed it to carve out a distinct niche in the market, often emphasizing the scientific rigor and innovative spirit behind their product lines. Giant Biogene's revenue flows primarily from its comprehensive suite of skincare products, which are distributed through a variety of channels, including e-commerce platforms and retail partnerships. The company taps into the rising demand for premium anti-aging and skin-repair products in China's robust beauty market. This inclination towards advanced skincare solutions is largely fueled by an increasingly affluent middle class that places high value on personal care and appearance. The company further augments its revenue streams by developing proprietary formulas and licensing these innovative technologies to other skincare brands, thereby capitalizing on its formidable R&D capabilities. By maintaining a symbiotic relationship between its research endeavors and market strategy, Giant Biogene continues to thrive as a vanguard of scientific beauty solutions amid evolving consumer preferences.

Giant Biogene Holding Co Ltd Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
37%
=
Net Income
¥2.3B
/
Revenue
¥6.1B
What is Giant Biogene Holding Co Ltd's current Net Margin?

The current Net Margin for Giant Biogene Holding Co Ltd is 37%, which is below its 3-year median of 38.8%.

How has Net Margin changed over time?

Over the last 2 years, Giant Biogene Holding Co Ltd’s Net Margin has decreased from 41.2% to 37%. During this period, it reached a low of 37% on Jul 30, 2025 and a high of 41.2% on Dec 1, 2023.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett